Analysis of [ADAP] Adaptimmune Therapeutics plc

Recently Launched!

Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information

Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos

Note: Free to use

Analysis of [ADAP] Adaptimmune Therapeutics plc

Data updated 2025-May-02 (Friday)

Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Note: Detail for Adaptimmune Therapeutics plc as of 2025-May-02 Market Close includes Performance (day & prior periods), Technical Indicators and Benchmarks. Use Related Links to view other info such as Seasonality, Correlations, Financials and Recent news for [NASDAQ:ADAP]

Share

Time machine widget shows Historical Detail for Adaptimmune Therapeutics plc on other dates (from 2015-May-06)

2025-May-02 Friday

Open	$0.28	High	$0.29 +4.21%
Close	$0.29	Low	$0.28 0.00%
Volume	479 Thousand 0.92x	Volatility	4.21%
Change	+$0.01 +3.93%	Streak	↑ 1 days +3.93%

20d SMA	$0.25 +13.3%	50d SMA	$0.35 -17.5%	100d SMA	$0.47 -39.4%	200d SMA	$0.72 -60.1%
RSI	51	MACD	0.02	ADX	20.7	Stochastic Oscillator	79.8 74.2
CCI	106.6	ATR	0.03	OBV	124 Million	Chaikin A/D	-126 Million

Market Cap	341 M	PEG Ratio		Trailing P/E		Forward P/E
Price/Sales (ttm)	4.6	Price/Book (mrq)	8.62	EV/Revenue (ttm)	3.63	EV/EBITDA (ttm)	-1.71

% Held by Insiders	0.21%	% Held by Institutions	70.02%	Shares Short	3.11 M	Shares Short (prior month)	2.93 M
Short Ratio	1.55	Short % of Outstanding	1.26%	Short % of Float	0.47%	Shares Short Change (mom)	+6.1%

Revenue/Share (ttm)	$0.30	Profit Margin (ttm)	-188.90%	Operating Margin (ttm)		EBITDA (ttm)	-128 M
Diluted EPS (ttm)	$-0.54	Current Ratio (mrq)	2.85	Return on Assets (ttm)	-28.22%	Return on Equity (ttm)	-187.61%
Qtr Earnings Growth (yoy)		Qtr Revenue Growth (yoy)	-97.90%	Operating Cash Flow (ttm)	-141 M	Free Cash Flow (ttm)	-73.8 M

Health Care Biotechnology ADR:GB

Alerts:

Choose view type

Daily Performance for Adaptimmune Therapeutics plc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)

Timespan 1w 2w 1m 2m 3m

Note: Performance over Key Timeperiods for Adaptimmune Therapeutics plc up to close of 2025-May-02 at $0.29

Period	Frequency	Performance	% off High	% off Low	Volatility	% off SMA	% off EMA	Relative Volume
01 Trailing 5-days	60% ↑40% ↓	+7.76%	-3.0%	+12.0%	11.5%	+3.7%	+3.7%	0.92x
02 Trailing 10-days	60% ↑40% ↓	+20.03%	-4.0%	+19.4%	25.0%	+6.9%	+6.4%	0.61x
03 Trailing 20-days	50% ↑50% ↓	-11.73%	-10.7%	+40.5%	60.0%	+13.3%	+5.3%	0.50x
04 Trailing 30-days	47% ↑53% ↓	+2.11%	-13.4%	+46.5%	65.0%	+12.9%	-1.7%	1.00x
05 Trailing 50-days	40% ↑60% ↓	-50.66%	-53.9%	+46.5%	210.0%	-17.5%	-16.2%	1.08x
06 Trailing 100-days	44% ↑56% ↓	-57.59%	-58.3%	+46.5%	245.0%	-39.4%	-37.9%	1.01x
07 Trailing 200-days	44% ↑57% ↓	-77.49%	-80.7%	+46.5%	640.0%	-60.1%	-54.6%	1.00x
08 Month-to-date	50% ↑50% ↓	+3.32%	-3.0%	+8.9%	11.5%
09 Quarter-to-date	57% ↑43% ↓	+45.13%	-13.4%	+46.5%	65.0%
10 Year-to-date	44% ↑56% ↓	-46.93%	-58.3%	+46.5%	245.0%
11 Trailing 52-weeks	43% ↑57% ↓	-75.97%	-80.7%	+46.5%	640.0%

1-month Performance Benchmarks for Adaptimmune Therapeutics plc:

Timespan 1w 2w 1m 2m 3m 6m 1y 2y 5y 10y 20y

Performance Absolute Relative

Compare Performance for Adaptimmune Therapeutics plc with other stocks/etfs/crypto in a side-by-side presentation using this widget

Related to Adaptimmune Therapeutics plc

Information for Adaptimmune Therapeutics plc

Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-02 on Google
SEC Reports : Quarterly reports around 2025-May-02 on SEC Edgar

Compare Adaptimmune Therapeutics plc with other assets

Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc

Analyze Adaptimmune Therapeutics plc in multiple dimensions using above resources. Other comparable assets include other stocks/etfs/crypto etc.

Symbol	Special	Category
$SPY	$market, $sp500	index
$IWM	$russell2000	index
$IWB	$russell1000	index
$XLC	$communication	sector
$XLY	$discretionary	sector
$XLP	$staples	sector
$XLE	$energy	sector
$XLF	$financials	sector
$XLV	$healthcare	sector
$XLK	$technology	sector
$XLI	$industriaks	sector
$XLB	$materials	sector
$XLRE	$realestate	sector
$XLU	$utilties	sector
$FXI	$china	region
$INDA	$india	region
$EWZ	$brazil	region
$EWC	$canada	region
$EWG	$germany	region
$EWJ	$japan	region
$EWW	$mexico	region
$EZA	$southafrica	region
$EWY	$korea	region
$EEM	$emerging	region
$EZU	$europe	region
$GLD	$gold	benchmarks
$SLV	$silver	benchmarks
$HYG	$highyield	benchmarks
$TLT	$treasuries	benchmarks
$VIG	$dividendgrowth	strategies
$VUG	$growth	strategies
$HDV	$highdividend	strategies
$MTUM	$momentum	strategies
$VTV	$value	strategies
$KBE	$banks	themes
$IBB	$biotech	themes
$ITB	$homebuilders	themes
$IPO	$ipos	themes
$VV	$largecap	themes
$VUG	$largecapgrowth	themes
$VTV	$largecapvalue	themes
$VO	$midcap	themes
$IWP	$midcapgrowth	themes
$IWS	$midcapvalue	themes
$VB	$smallcap	themes
$VBK	$smallcapgrowth	themes
$VBR	$smallcapvalue	themes
$BTCUSD	$btc	crypto
$ETHUSD	$eth	crypto
$ADAUSD	$cardano	crypto
$DOGEUSD	$doge	crypto
$LTCUSD	$litecoin	crypto
$XRPUSD	$ripple	crypto
$USDTUSD	$tether	crypto

Analysis of [ADAP] Adaptimmune Therapeutics plc

2025-May-02 Friday

Information for Adaptimmune Therapeutics plc

Compare Adaptimmune Therapeutics plc with other assets

Ask brAIn Experimental

Examples

Examples

Examples

Examples

Examples

Loading...

Analysis of [ADAP] Adaptimmune Therapeutics plc

2025-May-02 Friday

Information for Adaptimmune Therapeutics plc

Compare Adaptimmune Therapeutics plc with other assets

Ask brAIn Experimental